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-P e d i a t r i c s , S p f l d . ,MA,Univ. o f Mass. ,Dept. o f Chem. ,Amherst, MA A p r e s e r v a t i v e , benzyl alcohol, has been demonstrated t o accumulate t o p o t e n t i a l l y t o x i c l e v e l s i n preterm i n f a n t s . Subsequently, use o f benzyl alcohol has been c u r t a i l e d . Parabens a r e a l s o p r e s e r v a t i v e s which f i n d wide a p p l i c a t i o n i n t h e food,cosmet i c , and pharmaceutical i n d u s t r i e s . Ilowever, parabens have n o t been q u a n t i t a t e d when given with o t h e r medications,such a s gentamicin. The methyl e s t e r of parahydroxybenzoic acid(MP), if pres e n t i n s u f f i c i e n t concentration,may d i s p l a c e b i l i r u b i n from a lbumin.
A high p r e s s u r e l i q u i d chromatography technique was developed t o measure M P i n small(0.5ml) blood samples. M P was measured p r i o r t o and 1 h r . a f t e r an I M dose of gentamicin s u l f a t e i n p r e matures already r e c e i v i n g a n t i b i o t i c s . MP was p r e s e n t a t a conc e n t r a t i o n of 1.8mgfml i n t h i s gentamicin preparation. The mean concentration o f .23pg/ml p r e -i n j e c t i o n was n o t s i g n i f i c a n t l y d i f f e r e n t from a post-in j e c t i o n average concentration of .31ug/ml (n=8) .The h i g h e s t concentration observed(.73!Jg/ml) is two o r d e r s o f magnitude lower than t h a t f e l t t o be t o x i c f o r benzyl a l c o h o l . B W GA P r e Post Mean=l. 596kg 31.5 weeks .23Pg/ml .31 Ug/ml Range (1.021-2.169) (27-36) (. 00-. 58) 1.09-. 731 No s i g n i f i c a n t d i f f e r e n c e was found between means using a one taiEed t t e s t . Non-accumulation with h e p a t i c and r e n a l compromise has yet t o be demonstrated.
PREGNANT C O C A I N E ABUSERS AN0 THEIR INFANTS. Tove I ,
Rosen and Helen L . ~o h n s o n ( S~o n .
by ~.~.~a m e r
410
of P -O K~~ Presby.MedCtr. ,DeptPed,NY Cocaine (C) abuse i s a major public health problem. To study the e f f e c t s of C abuse on the course of pregnancy and infant development, we have been following 2 groups of pregnant women; one on C and one drug-free. The data were analyzed in 3 groups: GPI, drug-free; GP2, methadone maintenance(M1 and C abuse; GP3, C used in combir~stion with marijuana and/or alcohol. For a l l findings r e ported, p<.05. GPs 263 commenced prenatal c a r e l a t e r , with l e s s frequent c l i n i c v i s i t s and l e s s adequate n u t r i t i o n . Beer consumpt i o n was higher in GP2; hard liquor intake In GP3. C abuse was s i m i l a r in both groups, but marijuana abuse was g r e a t e r in GP3. Drug abuse decreased a s g e s t a t i o n progressed.
There were no d i f f e r e n c e s in the incidence of perinatal complic a t i o n s , 5min. Apgar score, o r g e s t a t i o n a l age. However, mean birthweight, head circumference(HC), and length(L) were s i g n i f ic a n t l y smaller in GP2. Mild t o moderate withdrawal symptoms o c c u r red in 73% of GP2 and 25% of GP3. Neonatal course was s i m i l a r in a l l groups. Infants with an uncomplicated course were enrolled in follow-up. At 6 mo., GP2 again demonstrated smaller weight, HC, and L, and more frequent hypertonicity and i r r i t a b i l i t y . T h e grows did not d i f f e r on t h e Bayley Scales o r any o t h e r v a r i a b l e s .
In conclusion, C abusers comprise a high r i s k group d u r i n g p r egnancy, with frequent multidrug abuse and poor n u t r i t i o n . The inf a n t s of mothers on both M and C appear t o be a t g r e a t e s t r i s k f o r low weight, HC, and L from b i r t h through 6 mo. While i n f a n t s of C abusers did not d i f f e r from c o n t r o l s in growth and development, only f u r t h e r follow-up w i l l show if any longterm e f f e c t s occur.
HEMODYNAMIC EFFECTS AND MARGIN-OF-SAFETY OF ISOFLU-
Ryan Cook, Gerald K. Shiu, Richard A. Orr (~p o n . by William H. Neches), Univ. of P i t t s b u r g h School of Med. and Child r e n ' s Hosp. of P i t t s b u r g h , Depts. of Anesthesia and P e d i a t r i c s , Pittsburgh, PA I s o f l u r a n e (ISO), a potent i n h a l a t i o n a n e s t h e t i c , i s commonly used f o r i n f a n t a n e s t h e s i a , but i t s cardiovascular e f f e c t s a r e poorly defined. We invasively measured t h e e f f e c t s of IS0 on t h e major determinants of c a r d i a c output i n 15 acutely-instrumented h e a l t h y newborn p i g l e t s and 9 age-matched c o n t r o l s . End-tidal IS0 concentrations were determined by mass spectrometry. Hemodynamic readings were obtained a t b a s e l i n e , 0.5, 1.0, and 1.3 M A C (minimum a l v e o l a r concentration needed f o r a n e s t h e s i a ) .
At 1 MAC: CI -5% (NS), MAP -37%*, systemic r e s i s t a n c e -32%*, dP/dT/DP40 -32%*, echo shortening f r a c t i o n -20%*, H R -15% (NS), LVEDP -18% (NS). 1.3 MAC IS0 d i d n o t depress any v a r i a b l e f u rt h e r , except H R (-19%") (*=p<.05 v s b a s e l i n e and c o n t r o l ) . 5 p i g s who had J. H R were paced; MAP, ~P /~T / D P~O , and systemic res i s t a n c e remained low while CI d i d not change. I n 12 other pigl e t s , t h e blood, h e a r t , and brainstem 1ethal:MAC concentration r a t i o was 2.1, 2.0, and 2.8, r e s p e c t i v e l y .
At 1 MAC, IS0 depressed c o n t r a c t i l i t y and occasionally caused bradycardia. Because MAP and systemic r e s i s t a n c e decreased t o a s i m i l a r e x t e n t , C I was unchanged.
J-MAP may adversely a f f e c t flow t o those v i t a l organs lacking mature autoregulation. IS0 has a l i m i t e d margin-of-safety i n newborn p i g l e t s . 
of P i t t s b u r g h School of Med. and C h i l d r e n ' s Hosp. of P i t t s b u r g h , Depts. of Anesthesia, P e d i a t r i c s , and Pharmacology, P i t t s b u r g h , PA
High-dose f e n t a n y l i s used f o r i n t r a -and p o s t o p e r a~i v e newborn c a r d i a c a n e s t h e s i a , y e t i t s pharmacodynamic e f f e c t s on t h e major determinants of c a r d i a c output i n t h e newborn a r e unknown.
We studied 25 acutely-instrumented h e a l t h y p i g l e t s < 2 wks old; 5 received 50 pg/kg IV f e n t a n y l (F), 5 c o n t r o l s received only 0.01-0.03 mg/kg IV a t r o p i n e (A) t o f i x HR, and 9 received both (F/A). F pharmacokinetics were studied i n 6 o t h e r s .
Mean plasma F concentrations were 25.4, 12.7, and 7.9 ngtml a t 5, 15, and 30 min, r e s p e c t i v e l y . T%(a)=2.1 min and Tk(6)' 35.8 min. P i g l e t s given only F had t h e i r maximum hemodynamic changes from b a s e l i n e a t 5 min: MAP +42%, C I -42% (thermodilut i o n ) , HR -36%, LVEDP +81%, and TPRI +93% (pC.05 v s b a s e l i n e f o r each v a r i a b l e ) . The degree of change c o r r e l a t e d well with t h e log F concentration (r=.98, pc.05).
In F p i g s , c o n t r a c t i l i t y (LV peak dp/dT and echo shortening f r a c t i o n ) d i d not change. However, p i g l e t s given F/A had no s i g n i f i c a n t hemodynamicchanges from b a s e l i n e , other than a 14% i n c r e a s e i n MAP, and were s t at i s t i c a l l y s i m i l a r t o t h e c o n t r o l group given A alone.
Fentanyl, when given alone, had adverse e f f e c t s on newborn p i g l e t s , but f e n t a n y l with a t r o p i n e d i d n o t a l t e r normal hemodynamics during t h e f i r s t elimination h a l f -l i f e .
The u s e of fent a n y l i s recommended f o r newborns provided a v a g o l y t i c agent i s used concomitantly.
SUFENTANIL: PHARMACOKINETIC AND HEMODYNAMIC PROPER-
L. S t i l l e r , D. Rvan Cook (Spon. by William H. Neches) Univ. of P i t t s b u r g h School of Med. and t h e Children's Hosp. of Pittsburgh, Depts. of Anesthesia, P e d i a t r i c s and Pharmacology, P i t t s b u r g h , PA S u f e n t a n i l (SUE) i s a potent n a r c o t i c r e c e n t l y approved f o r u s e i n a d u l t cardiac anesthesia.
Its hemodynamic and pharmacok i n e t i c p r o p e r t i e s a r e u n t e s t e d i n newborns. We measured plasma SUF concentrations by radioimmunoassay i n 7 h e a l t h y newborn pigl e t s given 15 pg/kg SUF by IV bolus.
Its e f f e c t s on t h e d e t e rminants of c a r d i a c output were invasively measured i n 6 p i g l e t s . Plasma SUE conc. f i t a 3-compartment model; T%(a)=2.0 min and Tk(6)=39.7 min. Cardiac e f f e c t s were compared with b a s e l i n e :
5 Min 15 Min 30 k i n 45 Min 60 Min ------15% -6% -2% +2% +15% MAP +16% +11% +15% +11% +9% CI (thennodilution) -267%" -16%" -23%" -29%" -32%" Systemic Resistance +58%* +28%* +49%* +60%* +69%* LV d~/ d~ +6% +19%* +28%* +19%* +36%* LVEDP +68% +16% -46% -78% -73% *p<.05 v s b a s e l i n e by repeated measures a n a l y s i s
The a and $-phase h a l f -l i v e s of SUF and f e n t a n y l (another potent n a r c o t i c ) a r e s i m i l a r i n t h e p i g l e t . Unlike f e n t a n y l , SUF does n o t a f f e c t MAP o r HR. C I i s depressed l e s s by SUF, perhaps because i t i n c r e a s e s c o n t r a c t i l i t y . Both drugs i n c r e a s e a f t e r l o a d . SUF does n o t a f f e c t preload s i g n i f i c a n t l y . Because SUF has a p o s i t i v e i n o t r o p i c e f f e c t with minimal adverse hemodynamic e f f e c t s on newborn p i g l e t s , i t m e r i t s a c l i n i c a l t r i a l i n newborn c a r d i a c a n e s t h e s i a .
PHARMACOKINETIC BASIS FOR ANTENATAL IY)SING OF PHENO-

A 1 A BARBITAL FOR THE PREVENTION OF NECNATAL INTRACERE-
--lq BRAL HEMORRHAGE. Seetha Shankaran, Eugene Cepeda, Nestor I l a g a n , Ralph Kauffman. Wayne S t a t e Univ. Sch. of Med, Children's Hosp of Mich., Dept. of Ped., D e t r o i t , M I .
Transplacental and e l i m i n a t i o n pharmacokinetics of phenobarbital (PB) were analyzed i n pregnant women and t h e i r neonates w i t h the a i m of determining t h e dose t o be administered t o pregnant women t o achieve l e v e l s i n t h e neonate f o r prevention of neonatal i n t r a c e r e b r a l hemorrhage (ICH). A s i n g l e PB dose of 500 mg was s e l e c t e d t o achieve a serum concentration of 10 ug/mL i n t h e women according t o t h e equation: dose (mg/Kg) = serum conc (ug/ mL) x Vd (L/Kg); assuming average weight t o be 50 Kg and Vd = 1.0 L/Kg. Twenty-five women i n premature l a b o r <35 wks g e s t a t i o n received 500 mg PB administered intravenously over 30 min. Average weight of t h e women was 6 9 . 1 % 13.5 Kg ( a l l values mean + SD); t h e a c t u a l mean dose of PB t h e r e f o r e was 7.5 5 1 . 4 mg/Kg. The mean time from PB a d m i n i s t r a t i o n t o d e l i v e r y was 5.6 5 4.6 h r s (range 16 min. t o 17 h r s ) . The maternal serum PB l e v e l a t d e l i v e r y was 8.8 5 1.2 pg/mL and t h e cord serum l e v e l was 9.0 + 1.8 pg/mL.
There was no c o r r e l a t i o n between t h e time from PB a d m i n i s t r a t i o n t o d e l i v e r y and t h e cord:maternal serum concentrat i o n r a t i o . This i n d i c a t e d t r a n s p l a c e n t a l e q u i l i b r a t i o n w i t h i n 16 min. of m t e r n a l dosing. Mean apparent t k of PB e s t i m a t e d i n 11 i n f a n t s was 175.5 5 45.6 h r s ; t h i s i s comparable with t k i n neonates r e c e i v i n g PB p o s t n a t a l l y .
Based on t h i s study, we r e c o m n d a 10 q / K g dose of PB f o r t h e pregnant woman t o achieve a l e v e l of 10 ug/mL.
This l e v e l h a s becn found t o b e p r o t e c t i v e a g a i n s t ICH (Shankaran e t a l , Ann Neurol Abstr #14, 1984).
